<DOC>
	<DOCNO>NCT02944175</DOCNO>
	<brief_summary>Cholinesterase inhibitor Neostigmine Edrophonium use reverse neuromuscular blockade surgery . However , drug relatively slow onset adverse effect associate stimulation muscarinic receptor . In addition , neostigmine use reverse profound blockade . Anesthetics may exert effect various facet cerebral function cerebral metabolic rate ( CMRO2 ) , cerebral blood flow ( CBF ) , cerebral blood flow-metabolism coupling , intra cranial pressure ( ICP ) , autoregulation , vascular response CO2 brain electrical activity . The net result effect anaesthetic agent combine systemic effect may prove beneficial detrimental already diseased brain . In neurosurgical patient , clear rapid recovery require early assess neurological status maintain cerebral oxygenation metabolism within normal physiological value may save sugammadex .</brief_summary>
	<brief_title>Cerebral Oxygenation Metabolism After Reversal Of Rocuronium : Comparison Between Sugammadex Versus Neostigmine</brief_title>
	<detailed_description>The aim study compare Sugammadex versus neostigmine reversal neuromuscular blockade rocuronium patient undergo supratentorial tumor resection . Comparison include hemodynamics , respiratory effort degree sedation . Indicators global cerebral oxygenation haemodynamics calculate use jugular bulb peripheral arterial blood sampling .</detailed_description>
	<mesh_term>Neostigmine</mesh_term>
	<mesh_term>Rocuronium</mesh_term>
	<mesh_term>Neuromuscular Blocking Agents</mesh_term>
	<criteria>American Society Anesthesiologists physical class status I III . Patients schedule elective supratentorial brain tumor resection Severe uncompensated cardiac disease . Severe uncompensated respiratory disease . Severe uncompensated hepatic disease . Severe uncompensated renal disease . Morbidly obese patient . Documented hypersensitivity one use drug . Surgery sit position Surgery prone position Patients alter level consciousness . Pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>